Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. - Wikidata - awgldk - TriplyDB

Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.

Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.

http://www.wikidata.org/entity/Q34450703

about

PTH receptor-1 signalling-mechanistic insights and therapeutic prospects Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic Pregnancies Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose.Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)The impact of dietary induced hyperparathyroidism on healthy and diseased periodontia: an experimental study in rats.A roadmap to the brittle bones of cystic fibrosis.Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone.Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials.A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.The Role of Parathyroid Hormone-Related Protein (PTHrP) in Osteoblast Response to Microgravity: Mechanistic Implications for Osteoporosis Development.Parathyroid hormone-related protein: an update.Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor.Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.Vitamin D expenditure is not altered in pregnancy and lactation despite changes in vitamin D metabolite concentrations Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation.Mammary-specific ablation of the calcium-sensing receptor during lactation alters maternal calcium metabolism, milk calcium transport, and neonatal calcium accrual.A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats Efficacy and safety of weekly alendronate plus vitamin D₃ 5600 IU versus weekly alendronate alone in Korean osteoporotic women: 16-week randomized trial Calcium economy in human pregnancy and lactation.Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones.Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis.Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response.Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery.Hypercalcemia of Malignancy and Colorectal Cancer.Hypercalcemia in Lung Cancer due to Simultaneously Elevated PTHrP and Ectopic Calcitriol Production: First Case Report.Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide.Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.Dual roles of parathyroid hormone related protein in TGF-β1 signaling and fibronectin up-regulation in mesangial cells.Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases

P2860

Q26798005-E8D808D9-35EC-4A73-9461-328654958EE6 Q26801481-F1F7C635-A055-4FB3-99DC-87347065A798 Q33738711-8E12B05F-5E60-44AA-85AD-36FC764CC25F Q33786830-7AAD482B-CC17-4AB0-B498-AB1F7FC74306 Q33984825-BDF5C8A5-CF9B-4A16-8EAD-72706086F06F Q34076818-FA11F0A5-A62B-4A38-A13F-F2C0B46BEACF Q34442832-8C909FB0-47A3-47E8-A24C-BA7A16D4207E Q34544553-4954B79D-74F4-48A8-9862-F15D19E7901C Q34625168-CBD9B592-E630-4377-80B3-163F79D74F7D Q35165694-8053BD3A-D91D-4904-8AB7-47DCA3C7BDDC Q35832437-B11E25AF-B5A3-4753-A8FB-5A06939878E4 Q36015924-E334FC99-69BD-4964-9101-3B0E2635BC7B Q36087241-D106E193-A477-49E3-BE8B-E9CAD0A5D083 Q36201545-8D45F00F-5BB1-4693-96E2-4FCF89AB90E8 Q36372640-8C701DE6-3AC5-46ED-8595-972F9CB45FC9 Q36599592-001332BB-A945-4A33-AB10-1D6631BDD339 Q36933985-94D439E0-68B3-41C6-8B6D-D4854031F989 Q36946514-6947A264-1364-4D1D-BF6F-3DADDE79321F Q37110969-86868AA0-D118-41BF-81B5-1D2D94B92555 Q37213526-6730B91A-5410-4CD2-8CD3-32F1E5C6C214 Q37321920-AFFDB3D3-B471-4120-9389-74DEC43CF205 Q37708212-5434A2F9-001E-4194-92E1-A65594A7E3C1 Q38034840-17308A79-1F32-45CD-9F31-6C75D2AC9D9D Q38257346-E20D349D-D864-415A-B543-99E3CC66015F Q38260285-7F77ED97-41C7-4FA7-8C26-D9E54D5859F3 Q38470745-70AEFA7D-8B26-4E39-B415-3EA3D0722737 Q38736716-6468BEFC-9B67-4CAA-B74B-4527FB3D4A93 Q38737740-D5F67917-B1BF-44F3-804F-E84E019C6A4A Q38782895-C69B6905-D2A4-445D-A41D-1ABB28680877 Q41023096-DB5FFF0C-3913-42C0-B7CB-E7E1F39998DE Q41111255-19FF0FF3-568C-4491-9FA5-29245309EF77 Q43012875-EE112B7D-9D9A-4B2B-8553-03C0FAB12F44 Q47099239-06F66887-FE37-4EDD-AF14-28EA6F8F0094 Q51771792-7528F2C9-3B03-4636-B88A-0D579393B612 Q57109145-3AE34B37-4DC9-4F9C-A064-084DE51CDB3B

P2860

Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.

http://www.wikidata.org/entity/Q34450703

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@ast

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@en

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@nl

type

label

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@ast

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@en

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@nl

prefLabel

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@ast

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@en

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@nl

P1433

Q34450703-75D4E351-B229-4576-9DAA-1ACA787EA606

P1476

Q34450703-451ED565-5E07-4DE7-9BF2-5AD561BD7475

P2093

Q34450703-079BFCAA-A6E8-4C00-9911-23246FCE6D8D

Q34450703-11E3AF7B-17F5-45E3-8A80-792397753DC6

Q34450703-25BCBE78-F9A2-4FB1-B096-3A97DFF9B31F

Q34450703-371882AE-5E15-499C-B310-BB31B40C98EE

Q34450703-4853188F-EB64-4566-88C8-BC60594897CA

Q34450703-6DD91761-F62B-4A45-B8F9-CEDBB1219C0C

Q34450703-7B49D98E-8B84-447D-A4A1-2FA6BF3A0E92

Q34450703-937EE434-56A4-4D88-BD3A-EAE1B47B13B7

Q34450703-ADFCBC88-F597-46CC-B6F6-0B756E1DA25F

Q34450703-DE235E2D-F590-4879-91A8-D8B93B91AD89

P304

Q34450703-739098D9-1DE5-48A3-B3F1-330D3543FDAF

P31

Q34450703-50639B0B-F23F-46B0-B638-3980D988BEF6

P356

Q34450703-182D1755-651E-45BA-A196-75AA19D66951

P433

Q34450703-FC52491C-32FF-406D-905E-FCFD1CEDFEB4

P478

Q34450703-BC262516-F2A3-4EF2-BB82-6403BAE5772A

P577

Q34450703-873201E7-F710-46E9-BFD1-8F46900E20B5

P698

Q34450703-9BDCF23E-6488-451C-A737-4B995FBCFCA1

P921

Q34450703-1E7D4FB8-B104-44C9-9273-359CD2963BCA

P356

P1433

Journal of Bone and Mineral Research

P1476

Continuous PTH and PTHrP infus ...... ffects on 1,25(OH)2 vitamin D.

@en

P2093

Adolfo Garcia-Ocaña

http://www.w3.org/2001/XMLSchema#string

Alessandro Bisello

http://www.w3.org/2001/XMLSchema#string

Andrew F Stewart

http://www.w3.org/2001/XMLSchema#string

Bruce W Hollis

http://www.w3.org/2001/XMLSchema#string

Caren Gundberg

http://www.w3.org/2001/XMLSchema#string

Clifford J Rosen

http://www.w3.org/2001/XMLSchema#string

John J Wysolmerski

http://www.w3.org/2001/XMLSchema#string

Mara J Horwitz

http://www.w3.org/2001/XMLSchema#string

Mary Beth Tedesco

http://www.w3.org/2001/XMLSchema#string

Mushtaq A Syed

http://www.w3.org/2001/XMLSchema#string

P304

1792-1803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.050602

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16160737

http://www.w3.org/2001/XMLSchema#string

P921